Skip to main content
Clinical Trials/ISRCTN89619994
ISRCTN89619994Completed未知

Time course of biochemical markers of inflammation, oxidative stress and wound healing after ablation of atrial fibrillation

Medical University of Vienna (Austria)0 sites30 target enrollmentStarted: December 11, 2007Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

  1. 2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/20692054 (added 31/05/2019) 2. 2012 results in: https://www.ncbi.nlm.nih.gov/pubmed/22102100 (added 31/05/2019)

Study Design

Study Type
Observational

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Genders eligible for study: both
  • 2. Age older than 18 years
  • 3. Symptomatic, drug-resistant paroxysmal atrial fibrillation (self-terminating episodes lasting less than 7 days)
  • 4. Patients referred to our department for catheter ablation of atrial fibrillation
  • 5. Adequate anticoagulation for at least 1 month prior to admission (oral anticoagulation (target International Normalised Ratio [INR] 2 to 3) or treatment with weight-adjusted low-molecular-weight heparin

Exclusion Criteria

  • 1. Pregnancy
  • 2. Ongoing infections
  • 3. Intracardiac thrombosis detected by trans-oesophageal echocardiography
  • 4. Contraindications to anticoagulation
  • 5. History of myocardial infarction or cardiac surgery within the last 3 months prior to admission
  • 6. Pacemaker or other contraindications to Magnetic Resonance Imaging (MRI)
  • 7. Denial or withdrawal of informed consent
  • 8. Life expectancy less than 1 year

Investigators

Sponsor
Medical University of Vienna (Austria)

Similar Trials